Universitätsklinikum Würzburg

Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (2021) Jetani H, Navarro-Bailón A, Maucher M, Frenz S, Verbruggen C, Yeguas A, Vidriales MB, et al. Journal article Cereblon enhancer methylation and IMiD resistance in multiple myeloma (2021) Haertle L, Barrio S, Munawar U, Han S, Zhou X, Vogt C, Fernandez RA, et al. Journal article 2021 European myeloma network review and consensus statement on smoldering multiple myeloma: How to distinguish (and manage) Dr. Jekyll and Mr. Hyde (2021) Musto P, Engelhardt M, Caers J, Bolli N, Kaiser M, Van De Donk N, Terpos E, et al. Journal article, Review article TUMOR-DERIVED GDF-15 PREVENTS THERAPY SUCCESS OF CHECKPOINT INHIBITORS BY BLOCKING T-LYMPHOCYTE RECRUITMENT (2021) Haake M, Schaefer T, Haack B, Vashist N, Genssler S, Harter P, Martens A, et al. Conference contribution The riskiest psychological intervention? Positive and negative side effects of exposure for anxiety disorders (2021) Heinig I, Knappe S, Wittchen HU, Hoyer J, Arolt V, Diaeresis J, Domschke K, et al. Conference contribution T-Cell Metabolism in Graft Versus Host Disease (2021) Karl F, Hudecek M, Berberich-Siebelt F, Mackensen A, Mougiakakos D Journal article, Review article Genetic risk of CMV reactivation? (2021) Einsele H, Kraus S Journal article Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis (2021) Zaremba A, Kramer R, De Temple V, Bertram S, Salzmann M, Gesierich A, Reinhardt L, et al. Journal article Single- And double-hit events in genes encoding immune targets before and after T cell–engaging antibody therapy in MM (2021) Truger MS, Duell J, Zhou X, Heimeshoff L, Ruckdeschel A, John M, Riedel A, et al. Journal article Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party (2021) Hayden PJ, Eikema DJ, De Wreede LC, Koster L, Kroger N, Einsele H, Minnema M, et al. Journal article